APIXABAN FOR THE REDUCTION OF THROMBO-EMBOLISM IN PATIENTS WITH DEVICE-DETECTED SUB-CLINICAL ATRIAL FIBRILLATION

Upcoming Events

There are no upcoming events at this time.

Twitter


Congratulations #ARTESiA Dr. Taya Glotzer and Study Coordinator Patricia Arakelian, Jana Tancredi & Deborah O'Neill on enrolling the 750th patient in the USA!! We thank you for your continued support and dedication to the ARTESiA study! @PHRIresearch #Apixaban #SCAF https://t.co/BiKhUAxKEC

Atrial pacing as a new predictor for atrial high rate episodes in patients with dual-chamber pacemaker https://t.co/mf7vvo8DdV
Published in @RevEspCardiol REC: CardioClinics
@PHRIresearch @Artesia_RCT

Duration of atrial high-rate episodes and CHA2DS2-VASc score to predict cardiovascular and cerebrovascular events in patients with dual chamber permanent pacemakers

https://t.co/s0sL0YUudq published in Journal of Cardiology @PHRIresearch

LinkedIn